nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycerol Phenylbutyrate—PNLIP—Lipid and lipoprotein metabolism—MGLL—osteoporosis	0.0476	0.154	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Lipid and lipoprotein metabolism—P4HB—osteoporosis	0.0324	0.105	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.00947	0.0307	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.00898	0.0291	CbGpPWpGaD
Glycerol Phenylbutyrate—Abdominal pain upper—Ibandronate—osteoporosis	0.0088	0.0127	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain upper—Calcitriol—osteoporosis	0.00862	0.0125	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal discomfort—Estropipate—osteoporosis	0.00833	0.012	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal discomfort—Alendronate—osteoporosis	0.0082	0.0119	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal discomfort—Ibandronate—osteoporosis	0.00799	0.0115	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Calcium Acetate—osteoporosis	0.00756	0.0109	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain upper—Risedronate—osteoporosis	0.00726	0.0105	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.00698	0.0226	CbGpPWpGaD
Glycerol Phenylbutyrate—Flatulence—Etidronic acid—osteoporosis	0.00689	0.00997	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.0068	0.0221	CbGpPWpGaD
Glycerol Phenylbutyrate—Decreased appetite—Ergocalciferol—osteoporosis	0.00668	0.00966	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal discomfort—Risedronate—osteoporosis	0.00658	0.00952	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain upper—Zoledronate—osteoporosis	0.0063	0.00911	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Calcium Acetate—osteoporosis	0.00624	0.00902	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Estropipate—osteoporosis	0.00605	0.00875	CcSEcCtD
Glycerol Phenylbutyrate—Flatulence—Estropipate—osteoporosis	0.00596	0.00862	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Calcium Acetate—osteoporosis	0.00595	0.0086	CcSEcCtD
Glycerol Phenylbutyrate—Flatulence—Alendronate—osteoporosis	0.00588	0.00849	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Ibandronate—osteoporosis	0.0058	0.00839	CcSEcCtD
Glycerol Phenylbutyrate—Flatulence—Raloxifene—osteoporosis	0.00578	0.00835	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Calcium Acetate—osteoporosis	0.00575	0.00832	CcSEcCtD
Glycerol Phenylbutyrate—Flatulence—Ibandronate—osteoporosis	0.00572	0.00827	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal discomfort—Zoledronate—osteoporosis	0.00572	0.00826	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Calcium Acetate—osteoporosis	0.00553	0.008	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Ergocalciferol—osteoporosis	0.00551	0.00797	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal discomfort—Conjugated Estrogens—osteoporosis	0.0055	0.00796	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	0.00544	0.0176	CbGpPWpGaD
Glycerol Phenylbutyrate—Nausea—Calcium Acetate—osteoporosis	0.00517	0.00747	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—PKM—osteoporosis	0.00503	0.0163	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—SOST—osteoporosis	0.00503	0.0163	CbGpPWpGaD
Glycerol Phenylbutyrate—Dyspepsia—Etidronic acid—osteoporosis	0.00503	0.00727	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Ethinyl Estradiol—osteoporosis	0.00491	0.00709	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain upper—Estradiol—osteoporosis	0.00485	0.00702	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Estropipate—osteoporosis	0.00484	0.007	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Risedronate—osteoporosis	0.00478	0.00692	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—ANTXR2—osteoporosis	0.00477	0.0155	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—PGLS—osteoporosis	0.00477	0.0155	CbGpPWpGaD
Glycerol Phenylbutyrate—Flatulence—Risedronate—osteoporosis	0.00471	0.00681	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Raloxifene—osteoporosis	0.00469	0.00678	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Etidronic acid—osteoporosis	0.00467	0.00675	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Ibandronate—osteoporosis	0.00465	0.00672	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	0.00462	0.015	CbGpPWpGaD
Glycerol Phenylbutyrate—Nausea—Ergocalciferol—osteoporosis	0.00456	0.0066	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Pamidronate—osteoporosis	0.00455	0.00657	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Etidronic acid—osteoporosis	0.00451	0.00653	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal discomfort—Estradiol—osteoporosis	0.0044	0.00637	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Estropipate—osteoporosis	0.00435	0.00629	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Alendronate—osteoporosis	0.00428	0.00619	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Estropipate—osteoporosis	0.00427	0.00617	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Estropipate—osteoporosis	0.00426	0.00616	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PKM—osteoporosis	0.00422	0.0137	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—FDPS—osteoporosis	0.00422	0.0137	CbGpPWpGaD
Glycerol Phenylbutyrate—Dyspepsia—Raloxifene—osteoporosis	0.00421	0.00609	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Ibandronate—osteoporosis	0.00417	0.00603	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Zoledronate—osteoporosis	0.00415	0.00601	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Raloxifene—osteoporosis	0.00413	0.00597	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Ibandronate—osteoporosis	0.00412	0.00595	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Ibandronate—osteoporosis	0.00409	0.00591	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Ibandronate—osteoporosis	0.00408	0.0059	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—GSN—osteoporosis	0.00406	0.0132	CbGpPWpGaD
Glycerol Phenylbutyrate—Gastrointestinal pain—Estropipate—osteoporosis	0.00404	0.00584	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Calcitriol—osteoporosis	0.00403	0.00583	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Conjugated Estrogens—osteoporosis	0.004	0.00578	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PGLS—osteoporosis	0.004	0.013	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—GPD2—osteoporosis	0.004	0.013	CbGpPWpGaD
Glycerol Phenylbutyrate—Gastrointestinal pain—Alendronate—osteoporosis	0.00398	0.00575	CcSEcCtD
Glycerol Phenylbutyrate—Flatulence—Conjugated Estrogens—osteoporosis	0.00394	0.0057	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.00393	0.00568	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Raloxifene—osteoporosis	0.00391	0.00566	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Etidronic acid—osteoporosis	0.00391	0.00565	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Estropipate—osteoporosis	0.00391	0.00565	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Ibandronate—osteoporosis	0.00387	0.0056	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Alendronate—osteoporosis	0.00385	0.00556	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Risedronate—osteoporosis	0.00383	0.00554	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Calcitriol—osteoporosis	0.00379	0.00548	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Raloxifene—osteoporosis	0.00378	0.00547	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Ibandronate—osteoporosis	0.00375	0.00541	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Calcitriol—osteoporosis	0.00367	0.0053	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PNP—osteoporosis	0.00366	0.0119	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ATIC—osteoporosis	0.00366	0.0119	CbGpPWpGaD
Glycerol Phenylbutyrate—Nervous system disorder—Pamidronate—osteoporosis	0.00364	0.00526	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Etidronic acid—osteoporosis	0.00363	0.00525	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Etidronic acid—osteoporosis	0.0036	0.00521	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Etidronic acid—osteoporosis	0.0036	0.0052	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Etidronic acid—osteoporosis	0.00358	0.00517	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Estropipate—osteoporosis	0.00354	0.00512	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—LRP5—osteoporosis	0.00353	0.0115	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—SOST—osteoporosis	0.00353	0.0114	CbGpPWpGaD
Glycerol Phenylbutyrate—Asthenia—Alendronate—osteoporosis	0.00349	0.00505	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.00346	0.005	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Ethinyl Estradiol—osteoporosis	0.00345	0.00499	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Risedronate—osteoporosis	0.00344	0.00497	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Ibandronate—osteoporosis	0.0034	0.00491	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Etidronic acid—osteoporosis	0.00339	0.0049	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Estropipate—osteoporosis	0.00338	0.00489	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—LRP6—osteoporosis	0.00338	0.011	CbGpPWpGaD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Risedronate—osteoporosis	0.00337	0.00487	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Risedronate—osteoporosis	0.00337	0.00487	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Alendronate—osteoporosis	0.00333	0.00481	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Calcitriol—osteoporosis	0.00333	0.00481	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Zoledronate—osteoporosis	0.00332	0.00481	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.00327	0.00473	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Raloxifene—osteoporosis	0.00327	0.00473	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Pamidronate—osteoporosis	0.00327	0.00472	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Estropipate—osteoporosis	0.00327	0.00472	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—LTF—osteoporosis	0.00324	0.0105	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—RPL24—osteoporosis	0.00324	0.0105	CbGpPWpGaD
Glycerol Phenylbutyrate—Diarrhoea—Ibandronate—osteoporosis	0.00324	0.00469	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Pamidronate—osteoporosis	0.00323	0.00466	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Alendronate—osteoporosis	0.00322	0.00465	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Pamidronate—osteoporosis	0.0032	0.00463	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.0032	0.00463	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Estradiol—osteoporosis	0.0032	0.00463	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Pamidronate—osteoporosis	0.0032	0.00463	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Risedronate—osteoporosis	0.00319	0.00462	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PTH1R—osteoporosis	0.00319	0.0103	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CALCR—osteoporosis	0.00319	0.0103	CbGpPWpGaD
Glycerol Phenylbutyrate—Diarrhoea—Calcitriol—osteoporosis	0.00317	0.00459	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.00317	0.00458	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Raloxifene—osteoporosis	0.00316	0.00457	CcSEcCtD
Glycerol Phenylbutyrate—Flatulence—Estradiol—osteoporosis	0.00315	0.00456	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Estropipate—osteoporosis	0.00314	0.00454	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Ibandronate—osteoporosis	0.00313	0.00453	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Estropipate—osteoporosis	0.00312	0.0045	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Estropipate—osteoporosis	0.00311	0.0045	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—OXCT1—osteoporosis	0.00311	0.0101	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CA2—osteoporosis	0.00311	0.0101	CbGpPWpGaD
Glycerol Phenylbutyrate—Headache—Estropipate—osteoporosis	0.00309	0.00447	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Alendronate—osteoporosis	0.00309	0.00447	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Risedronate—osteoporosis	0.00309	0.00446	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Alendronate—osteoporosis	0.00307	0.00444	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Alendronate—osteoporosis	0.00307	0.00443	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Alendronate—osteoporosis	0.00305	0.00441	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Raloxifene—osteoporosis	0.00304	0.0044	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Pamidronate—osteoporosis	0.00303	0.00439	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—MGLL—osteoporosis	0.00303	0.00983	CbGpPWpGaD
Glycerol Phenylbutyrate—Rash—Raloxifene—osteoporosis	0.00302	0.00436	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Raloxifene—osteoporosis	0.00301	0.00436	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Ibandronate—osteoporosis	0.00301	0.00435	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Raloxifene—osteoporosis	0.003	0.00433	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Ibandronate—osteoporosis	0.00299	0.00432	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Ibandronate—osteoporosis	0.00298	0.00431	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Zoledronate—osteoporosis	0.00298	0.00431	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Ibandronate—osteoporosis	0.00297	0.00429	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Calcitriol—osteoporosis	0.00295	0.00426	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Zoledronate—osteoporosis	0.00295	0.00426	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Estropipate—osteoporosis	0.00293	0.00424	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Pamidronate—osteoporosis	0.00293	0.00424	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Zoledronate—osteoporosis	0.00293	0.00423	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Calcitriol—osteoporosis	0.00292	0.00423	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Zoledronate—osteoporosis	0.00292	0.00423	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Calcitriol—osteoporosis	0.00292	0.00422	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Calcitriol—osteoporosis	0.00291	0.0042	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Alendronate—osteoporosis	0.00289	0.00418	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Conjugated Estrogens—osteoporosis	0.00287	0.00415	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Ethinyl Estradiol—osteoporosis	0.00287	0.00415	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	0.00286	0.00927	CbGpPWpGaD
Glycerol Phenylbutyrate—Nausea—Raloxifene—osteoporosis	0.00284	0.00411	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Conjugated Estrogens—osteoporosis	0.00284	0.0041	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.00282	0.00407	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Conjugated Estrogens—osteoporosis	0.00281	0.00407	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Ibandronate—osteoporosis	0.00281	0.00407	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—ACP5—osteoporosis	0.00281	0.00913	CbGpPWpGaD
Glycerol Phenylbutyrate—Asthenia—Risedronate—osteoporosis	0.0028	0.00405	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Zoledronate—osteoporosis	0.00277	0.00401	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Calcitriol—osteoporosis	0.00275	0.00398	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.00274	0.00396	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Zoledronate—osteoporosis	0.00268	0.00387	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Risedronate—osteoporosis	0.00267	0.00386	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.00267	0.00386	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Pamidronate—osteoporosis	0.00266	0.00385	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Ethinyl Estradiol—osteoporosis	0.00265	0.00383	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—TPI1—osteoporosis	0.00262	0.00848	CbGpPWpGaD
Glycerol Phenylbutyrate—Dizziness—Risedronate—osteoporosis	0.00258	0.00373	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Conjugated Estrogens—osteoporosis	0.00258	0.00373	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—IDH2—osteoporosis	0.00258	0.00836	CbGpPWpGaD
Glycerol Phenylbutyrate—Nervous system disorder—Estradiol—osteoporosis	0.00256	0.0037	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Ethinyl Estradiol—osteoporosis	0.00255	0.00368	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Pamidronate—osteoporosis	0.00254	0.00367	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—MGLL—osteoporosis	0.00253	0.00822	CbGpPWpGaD
Glycerol Phenylbutyrate—Rash—Ethinyl Estradiol—osteoporosis	0.00252	0.00365	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Ethinyl Estradiol—osteoporosis	0.00252	0.00365	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Ethinyl Estradiol—osteoporosis	0.00251	0.00363	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Risedronate—osteoporosis	0.00248	0.00359	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—LRP5—osteoporosis	0.00247	0.00802	CbGpPWpGaD
Glycerol Phenylbutyrate—Rash—Risedronate—osteoporosis	0.00246	0.00356	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Risedronate—osteoporosis	0.00246	0.00356	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—P4HB—osteoporosis	0.00246	0.00798	CbGpPWpGaD
Glycerol Phenylbutyrate—Dizziness—Pamidronate—osteoporosis	0.00245	0.00355	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Risedronate—osteoporosis	0.00245	0.00354	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Zoledronate—osteoporosis	0.00243	0.00352	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CYP27A1—osteoporosis	0.00242	0.00786	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—GAPDH—osteoporosis	0.00241	0.00783	CbGpPWpGaD
Glycerol Phenylbutyrate—Nausea—Ethinyl Estradiol—osteoporosis	0.00238	0.00344	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—LRP6—osteoporosis	0.00236	0.00767	CbGpPWpGaD
Glycerol Phenylbutyrate—Vomiting—Pamidronate—osteoporosis	0.00236	0.00341	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ACP5—osteoporosis	0.00236	0.00764	CbGpPWpGaD
Glycerol Phenylbutyrate—Asthenia—Conjugated Estrogens—osteoporosis	0.00234	0.00339	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Pamidronate—osteoporosis	0.00234	0.00338	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Pamidronate—osteoporosis	0.00234	0.00338	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	0.00233	0.00755	CbGpPWpGaD
Glycerol Phenylbutyrate—Headache—Pamidronate—osteoporosis	0.00233	0.00336	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Zoledronate—osteoporosis	0.00232	0.00335	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Risedronate—osteoporosis	0.00232	0.00335	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Estradiol—osteoporosis	0.0023	0.00332	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—NFATC1—osteoporosis	0.00229	0.00744	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—DKK1—osteoporosis	0.00228	0.00738	CbGpPWpGaD
Glycerol Phenylbutyrate—Decreased appetite—Estradiol—osteoporosis	0.00227	0.00328	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Estradiol—osteoporosis	0.00226	0.00326	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Estradiol—osteoporosis	0.00225	0.00326	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Zoledronate—osteoporosis	0.00224	0.00324	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Conjugated Estrogens—osteoporosis	0.00223	0.00323	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Pamidronate—osteoporosis	0.0022	0.00319	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—WNT1—osteoporosis	0.00219	0.00711	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—TPI1—osteoporosis	0.00219	0.0071	CbGpPWpGaD
Glycerol Phenylbutyrate—Dizziness—Conjugated Estrogens—osteoporosis	0.00216	0.00312	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Zoledronate—osteoporosis	0.00216	0.00312	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Zoledronate—osteoporosis	0.00214	0.00309	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Estradiol—osteoporosis	0.00214	0.00309	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Zoledronate—osteoporosis	0.00214	0.00309	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—FGA—osteoporosis	0.00213	0.00692	CbGpPWpGaD
Glycerol Phenylbutyrate—Headache—Zoledronate—osteoporosis	0.00212	0.00307	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Conjugated Estrogens—osteoporosis	0.00208	0.003	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Estradiol—osteoporosis	0.00207	0.00299	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—P4HB—osteoporosis	0.00206	0.00668	CbGpPWpGaD
Glycerol Phenylbutyrate—Rash—Conjugated Estrogens—osteoporosis	0.00206	0.00298	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Conjugated Estrogens—osteoporosis	0.00206	0.00297	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Conjugated Estrogens—osteoporosis	0.00205	0.00296	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—GAPDH—osteoporosis	0.00202	0.00656	CbGpPWpGaD
Glycerol Phenylbutyrate—Nausea—Zoledronate—osteoporosis	0.00201	0.00291	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—TLN1—osteoporosis	0.002	0.00648	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—RAP1A—osteoporosis	0.00197	0.00639	CbGpPWpGaD
Glycerol Phenylbutyrate—Nausea—Conjugated Estrogens—osteoporosis	0.00194	0.0028	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—ENO1—osteoporosis	0.0019	0.00616	CbGpPWpGaD
Glycerol Phenylbutyrate—Asthenia—Estradiol—osteoporosis	0.00187	0.00271	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—PSMA5—osteoporosis	0.00187	0.00607	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—PSMA2—osteoporosis	0.00187	0.00607	CbGpPWpGaD
Glycerol Phenylbutyrate—Diarrhoea—Estradiol—osteoporosis	0.00179	0.00258	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—CALCA—osteoporosis	0.00174	0.00566	CbGpPWpGaD
Glycerol Phenylbutyrate—Dizziness—Estradiol—osteoporosis	0.00173	0.0025	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—P4HB—osteoporosis	0.00172	0.00559	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—POMC—osteoporosis	0.00172	0.00557	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PTH—osteoporosis	0.00167	0.00543	CbGpPWpGaD
Glycerol Phenylbutyrate—Vomiting—Estradiol—osteoporosis	0.00166	0.0024	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Estradiol—osteoporosis	0.00165	0.00238	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—RAP1A—osteoporosis	0.00165	0.00534	CbGpPWpGaD
Glycerol Phenylbutyrate—Dermatitis—Estradiol—osteoporosis	0.00165	0.00238	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Estradiol—osteoporosis	0.00164	0.00237	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CNR2—osteoporosis	0.00163	0.00529	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—NFATC1—osteoporosis	0.00161	0.00521	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—DKK1—osteoporosis	0.00159	0.00517	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ENO1—osteoporosis	0.00159	0.00516	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—KL—osteoporosis	0.00158	0.00514	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PSMA2—osteoporosis	0.00157	0.00509	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PSMA5—osteoporosis	0.00157	0.00509	CbGpPWpGaD
Glycerol Phenylbutyrate—Nausea—Estradiol—osteoporosis	0.00155	0.00224	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—WNT1—osteoporosis	0.00153	0.00498	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—FGA—osteoporosis	0.00149	0.00484	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PTHLH—osteoporosis	0.00139	0.0045	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—BMP2—osteoporosis	0.00139	0.0045	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—FGB—osteoporosis	0.00136	0.00441	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PSMA5—osteoporosis	0.00131	0.00425	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PSMA2—osteoporosis	0.00131	0.00425	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CYP19A1—osteoporosis	0.00127	0.00413	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—ADCY5—osteoporosis	0.00124	0.00403	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CALCA—osteoporosis	0.00122	0.00396	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—MTHFR—osteoporosis	0.00114	0.0037	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—KL—osteoporosis	0.00111	0.0036	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—IRS2—osteoporosis	0.00109	0.00352	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ADCY5—osteoporosis	0.00104	0.00337	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—GPX1—osteoporosis	0.00104	0.00336	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—MTHFR—osteoporosis	0.000956	0.0031	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—IRS1—osteoporosis	0.000948	0.00308	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—IL6R—osteoporosis	0.000891	0.00289	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—ADCY5—osteoporosis	0.000869	0.00282	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—SPP1—osteoporosis	0.000841	0.00273	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—POMC—osteoporosis	0.000765	0.00248	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—IRS2—osteoporosis	0.00076	0.00247	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—LEP—osteoporosis	0.000744	0.00241	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—ESR1—osteoporosis	0.00071	0.0023	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—IRS1—osteoporosis	0.000664	0.00215	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—POMC—osteoporosis	0.000639	0.00207	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—IL6R—osteoporosis	0.000624	0.00202	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—IGF1—osteoporosis	0.000615	0.00199	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—MYC—osteoporosis	0.000528	0.00171	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—TGFB1—osteoporosis	0.000526	0.00171	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—IL6—osteoporosis	0.000397	0.00129	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—MYC—osteoporosis	0.00037	0.0012	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—TGFB1—osteoporosis	0.000369	0.0012	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—IL6—osteoporosis	0.000278	0.000901	CbGpPWpGaD
